Cargando…
The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas
Despite the high frequency of EGFR and TP53 genetic alterations in gliomas, little is known about their crosstalk during tumor progression. Here, we described a mutually exclusive distribution between mutations in these two genes. We found that wild-type p53 gliomas are more aggressive than their mu...
Autores principales: | Segura-Collar, Berta, Gargini, Ricardo, Tovar-Ambel, Elena, Hernández-SanMiguel, Esther, Epifano, Carolina, Pérez de Castro, Ignacio, Hernández-Laín, Aurelio, Casas-Tintó, Sergio, Sánchez-Gómez, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017250/ https://www.ncbi.nlm.nih.gov/pubmed/31947645 http://dx.doi.org/10.3390/cancers12010208 |
Ejemplares similares
-
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma
por: Hernández-SanMiguel, Esther, et al.
Publicado: (2019) -
Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target
por: Gargini, Ricardo, et al.
Publicado: (2020) -
Novel Functions of the Neurodegenerative-Related Gene Tau in Cancer
por: Gargini, Ricardo, et al.
Publicado: (2019) -
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype
por: Cejalvo, Teresa, et al.
Publicado: (2020) -
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)